A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.

Journal of Medicinal Chemistry
Sarah Wagner-GriffinMatthew D Disney

Abstract

Myotonic dystrophy type 2 (DM2) is one of >40 microsatellite disorders caused by RNA repeat expansions. The DM2 repeat expansion, r(CCUG)exp (where "exp" denotes expanded repeating nucleotides), is harbored in intron 1 of the CCHC-type zinc finger nucleic acid binding protein (CNBP). The expanded RNA repeat causes disease by a gain-of-function mechanism, sequestering various RNA-binding proteins including the pre-mRNA splicing regulator MBNL1. Sequestration of MBNL1 results in its loss-of-function and concomitant deregulation of the alternative splicing of its native substrates. Notably, this r(CCUG)exp causes retention of intron 1 in the mature CNBP mRNA. Herein, we report druglike small molecules that bind the structure adopted by r(CCUG)exp and improve DM2-associated defects. These small molecules were optimized from screening hits from an RNA-focused small-molecule library to afford a compound that binds r(CCUG)exp specifically and with nanomolar affinity, facilitates endogenous degradation of the aberrantly retained intron in which it is harbored, and rescues alternative splicing defects.

References

Nov 1, 1995·Journal of Biomolecular NMR·F DelaglioA Bax
Oct 9, 2001·Human Molecular Genetics·A MankodiC A Thornton
Jul 26, 2005·Nature Genetics·Jernej UleRobert B Darnell
Jan 6, 2012·Analytical and Bioanalytical Chemistry·Catherine Z ChenChristopher P Austin
Dec 18, 2013·ACS Chemical Biology·Jessica L Childs-DisneyMatthew D Disney
Apr 28, 2016·Bioorganic & Medicinal Chemistry Letters·Matthew G CostalesMatthew D Disney
Sep 20, 2017·Journal of Medicinal Chemistry·David A DeGoeyMichael D Wendt
Apr 4, 2018·Proceedings of the National Academy of Sciences of the United States of America·Łukasz J SznajderMaurice S Swanson
Jul 3, 2018·ACS Combinatorial Science·Hafeez S HaniffMatthew D Disney
Sep 15, 2018·The Journal of Biological Chemistry·John Douglas ClearyLaura P W Ranum
Mar 31, 2019·Proceedings of the National Academy of Sciences of the United States of America·Alicia J AngelbelloMatthew D Disney
Jul 20, 2019·Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms·Melissa A HaleJ Andrew Berglund
Jan 23, 2020·Proceedings of the National Academy of Sciences of the United States of America·Matthew G CostalesMatthew D Disney
Jul 14, 2020·Journal of Medicinal Chemistry·Raphael I BenhamouMatthew D Disney
Nov 7, 2020·Cell Chemical Biology·Alicia J AngelbelloMatthew D Disney

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.